[LXRX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
06-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 9.98%
YoY- -137.37%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 8,727 17,071 33,047 23,037 127,280 21,482 1,410 35.48%
PBT -51,138 -16,781 -32,387 -32,419 86,750 -3,003 -17,414 19.65%
Tax 335 -102 -4,009 37 1,612 -70 -174 -
NP -51,138 -16,781 -28,378 -32,419 86,750 -2,933 -17,414 19.65%
Tax Rate - - - - -1.86% - - -
Total Cost 59,865 33,852 61,425 55,456 40,530 24,415 18,824 21.25%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -585.97 -98.30 -85.87 -140.73 68.16 -13.65 -1,235.04 -11.68%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.48 -0.16 -0.27 -0.31 0.84 -0.03 -0.24 12.24%
EPS Diluted -0.48 -0.16 -0.27 -0.31 0.76 -0.03 -0.24 12.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.